Tackling anthrax.
Friedlander
A M
AM
D000881:Anthrax / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D000907:Antibodies, Bacterial / Q000276:immunology; D000942:Antigens, Bacterial; D000992:Antitoxins / Q000627:therapeutic use*; D001408:Bacillus anthracis / Q000235:genetics / Q000276:immunology / Q000502:physiology; D001427:Bacterial Toxins / Q000037:antagonists & inhibitors* / Q000737:chemistry; D023482:Bioterrorism / Q000517:prevention & control*; D016680:Genome, Bacterial; D006801:Humans; D011487:Protein Conformation; D018000:Receptors, Peptide / Q000032:analysis / Q000737:chemistry; D013171:Spores, Bacterial
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D000992:Antitoxins; D001427:Bacterial Toxins; D018000:Receptors, Peptide; C030325:anthrax toxin; C070309:anthrax toxin receptors